NCCN practice guidelines for the myelodysplastic syndromes

ONCOLOGY

Volumn 12, Issue 11 A, 1998, Pages 53-80

  Greenberg, P ^a   Bishop, M ^a   Deeg, J ^a   Estey, E ^a   Erba, H ^a   Gore, S ^a   Nimer, S ^a   O'Donnell, M ^a   Stone, R ^a   Tallman, M ^a   Bennett, J ^a  

^a NCCN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; AZACITIDINE; CYCLOSPORIN; CYTARABINE; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; LISOFYLLINE; PENTOXIFYLLINE; RETINOID; VITAMIN D DERIVATIVE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANEMIA; CANCER GROWTH; CLINICAL FEATURE; CLINICAL PROTOCOL; CONFERENCE PAPER; DISEASE CLASSIFICATION; FOLLOW UP; HUMAN; MYELODYSPLASTIC SYNDROME; PRACTICE GUIDELINE; PROGNOSIS; TREATMENT PLANNING;

AGED; ANEMIA; DECISION TREES; HUMANS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS;

EID: 0032406633     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)